What are the Best Approaches to Monitor and Manage Vascular Toxicity in Cardio-Oncology?

What are the Best Approaches to Monitor and Manage Vascular Toxicity in Cardio-Oncology?

Mayo Clinic cardiologist, Joerg Herrmann, MD, provides a review of the three main types of presentation of vascular toxicity seen with chemotherapy: acute vasospasm, acute thrombosis, and accelerated atherosclerosis. Each type is illustrated by a case example, followed by a concise review of the presently known underlying mechanisms. Recommendations for screening, prevention, and management conclude each vascular toxicity type chapter. In a building block format the practitioners will be equipped to recognize and manage vascular toxicity of cancer therapy in daily practice.


Created by

Medical Professional Education Center

Presenters

Joerg Herrmann, MD

Joerg Herrmann, MD

Director, Cardio-Oncology Clinic
Mayo Clinic, Rochester, MN

Joerg Herrmann, M.D., is a board-certified cardiologist. He attended Medical School in Germany and obtained specialty training in internal medicine, cardiology, and interventional cardiology at Mayo Clinic in Rochester, Minnesota.